CN118401838A - 测定粪便中弹性蛋白酶1的方法 - Google Patents

测定粪便中弹性蛋白酶1的方法 Download PDF

Info

Publication number
CN118401838A
CN118401838A CN202280078422.3A CN202280078422A CN118401838A CN 118401838 A CN118401838 A CN 118401838A CN 202280078422 A CN202280078422 A CN 202280078422A CN 118401838 A CN118401838 A CN 118401838A
Authority
CN
China
Prior art keywords
antitrypsin
alpha
reagent
sample
α1at
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280078422.3A
Other languages
English (en)
Chinese (zh)
Inventor
佐藤淳史
长滨裕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN118401838A publication Critical patent/CN118401838A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/966—Elastase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/067—Pancreatitis or colitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN202280078422.3A 2021-11-30 2022-11-30 测定粪便中弹性蛋白酶1的方法 Pending CN118401838A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-194361 2021-11-30
JP2021194361 2021-11-30
PCT/JP2022/044078 WO2023100910A1 (ja) 2021-11-30 2022-11-30 糞便中エラスターゼ１を測定する方法

Publications (1)

Publication Number Publication Date
CN118401838A true CN118401838A (zh) 2024-07-26

Family

ID=86612196

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280078422.3A Pending CN118401838A (zh) 2021-11-30 2022-11-30 测定粪便中弹性蛋白酶1的方法

Country Status (6)

Country Link
US (1) US20250035630A1 (https=)
EP (1) EP4443160A4 (https=)
JP (1) JPWO2023100910A1 (https=)
KR (1) KR20240108487A (https=)
CN (1) CN118401838A (https=)
WO (1) WO2023100910A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617299B2 (ja) * 1986-09-17 1997-06-04 ダイナボット 株式会社 エラスターゼ１の免疫学的測定方法
JPH0525715Y2 (https=) 1986-10-31 1993-06-29
JPH03215747A (ja) * 1990-01-19 1991-09-20 Maruko Seiyaku Kk エラスターゼ１の酵素免疫学的測定方法および測定用試薬
DE4107765A1 (de) * 1990-07-28 1992-01-30 Schebo Tech Medizinisch Biolog Pankreas-elastase-1-spezifischer antikoerper, ein verfahren zu seiner gewinnung und ein testkit der solche antikoerper enthaelt
JP4530539B2 (ja) * 1998-09-08 2010-08-25 プリファテス インスティトゥット バイオサルフ ゲーエムベーハー 膵機能障害認識のための診断方法
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
JPWO2002079782A1 (ja) 2001-03-30 2004-07-22 株式会社三菱化学ヤトロン エラスターゼ１の免疫分析用試薬及び免疫分析方法並びに膵疾患の検出方法
EP2947459B1 (en) 2014-05-21 2017-07-12 Bühlmann Laboratories AG Method for determination of a protein

Also Published As

Publication number Publication date
WO2023100910A1 (ja) 2023-06-08
EP4443160A4 (en) 2025-11-19
EP4443160A1 (en) 2024-10-09
KR20240108487A (ko) 2024-07-09
US20250035630A1 (en) 2025-01-30
JPWO2023100910A1 (https=) 2023-06-08

Similar Documents

Publication Publication Date Title
US20070178443A1 (en) Method for diagnosing liver fibrosis
JP2003524187A (ja) 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
US20140186863A1 (en) Method for detecting pancreatic disease marker
US5994085A (en) Methods and devices for detecting non-complexed prostate specific antigen
US20070178442A1 (en) Method for diagnosing liver fibrosis
JP4751555B2 (ja) 脳卒中のための診断アッセイ
CN102656457A (zh) 用于诊断前列腺癌的试剂盒和方法
US20070254317A1 (en) Method for Detecting the Activatable Free Form of Psa and the Use Thereof for Diagnosing Benign Pathologies of the Prostate and Adenocarcinoma of the Prostate
EP1887358B1 (en) Method of immunologically analyzing plasmin degradation product of stabilized fibrin
CN118638739B (zh) Gsdmd在胸痛相关疾病诊断及疗效评估上的用途
JP5648905B2 (ja) 肝臓がん発症の検出又はリスクの予測方法
CN118401838A (zh) 测定粪便中弹性蛋白酶1的方法
JP4814788B2 (ja) 間質性膀胱炎の検査方法
HK40109997A (en) Method for measuring elastase 1 in feces
EP4317991A1 (en) Highly sensitive immunoassay reagent and measurement method
EP4232828B1 (en) Methods and kits for diagnosing covid-19 disease
JP7446882B2 (ja) 被験者のスクリ－ニング方法及び鑑別方法
WO1995027900A1 (en) Method of discriminating vaginal secretion or cervical mucus of gravida suspected of threatened premature delivery
CN118085097A (zh) 一种胃蛋白酶a特异抗体及其应用
HK40106382A (en) Highly sensitive immunoassay reagent and measurement method
JP2024027767A (ja) 可溶型ｃｌｅｃ２を用いた血小板減少性疾患の診断法
Kagawa et al. Development of a novel clinical diagnostic method for detection of the glycosylation changes in liver fibrosis
JPH0968524A (ja) 消化管疾患の検出方法
KR20240151234A (ko) 세린 프로테아제의 검출용 또는 측정용 시약
CN121613114A (zh) 一种基于中性粒细胞迁移体及其标志物检测的弥散性血管内凝血早期诊断方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination